The acrimony grew in billionaire Ken Evenstad's family slowly, then ripped the family apart in the last years of his life.
Evenstad, who died in late 2020, made a fortune by driving a small Minneapolis drug company in the 1970s into the then-nascent market for generic drugs. The firm — Upsher-Smith Laboratories, now in Maple Grove — became a significant player in generics and developed dozens of its own drugs.
But as he battled pulmonary disease in his final years, Evenstad also struggled to separate the family from Upsher-Smith — which had no other shareholders except himself, his wife Grace, their daughter Serene and son Mark.
The family decided in 2016 to put Upsher-Smith up for sale. A year after the first and biggest transaction in that process took place, Serene filed suit against the rest of the family alleging they were trying to freeze her out.
The case reached a climax last week, when lawyers made their closing arguments before a Hennepin County District Court judge who will decide whether Ken, Grace and Mark cheated Serene out of tens of millions of dollars.
"We are not in family court. … The shareholder relationships are different from the family relationships," Thomas Swigert, one of Serene's attorneys, told Judge Edward Wahl in a hearing conducted over Zoom Friday.
"As a shareholder, she has legal rights," he added. "It doesn't matter how she received her shares. It doesn't matter whether she worked at the company. Nor does it matter how much money she has."
Lawyers representing Ken's estate, Grace, Mark and trust attorney Howard Rubin portrayed Serene as a selfish attention-seeker who should be happy with the approximately $200 million she has received since 2017.